Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 7 Issue 1 Pages: 1-8 Pub: 2015 Mar Epub: Authors Baca-Castañón ML , De la Garza-Ramos MA , Alcázar-Pizaña AG , Grondin Y , Coronado-Mendoza A , Sánchez-Najera RI , Cárdenas-Estrada E , Medina-De la Garza CE , Escamilla-García E , |
|
|
Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 7 Issue 1 Pages: 1-8 Pub: 2015 Mar Epub: Authors Baca-Castañón ML , De la Garza-Ramos MA , Alcázar-Pizaña AG , Grondin Y , Coronado-Mendoza A , Sánchez-Najera RI , Cárdenas-Estrada E , Medina-De la Garza CE , Escamilla-García E , |
|
|
Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia. β
Go to Publication β
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 7 Issue 1 Pages: 1-8 Pub: 2015 Mar Epub: Authors Baca-Castañón ML , De la Garza-Ramos MA , Alcázar-Pizaña AG , Grondin Y , Coronado-Mendoza A , Sánchez-Najera RI , Cárdenas-Estrada E , Medina-De la Garza CE , Escamilla-García E , |
|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. β
Go to Publication β
PloS one (PLoS One ) Vol: 10 Issue 5 Pages: e0125812 Pub: 2015 Epub: 2015 May 6 Authors Romani Vestman N , Chen T , Lif Holgerson P , Öhman C , Johansson I , |
|
|
Antimicrobial Properties of a Potential Probiotic Lactobacillus from Thai Newborn Feces. β
Journal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai ) Vol: 98 Suppl 9 Issue Pages: S116-22 Pub: 2015 Oct Epub: Authors Chimchang J , Theparee T , Ladda B , Tanasupawat S , Wongsatayanon BT , Taweechotipatr M , |
|
|
Effect of Formula Containing Lactobacillus reuteri DSM 17938 on Fecal Microbiota of Infants Born by Cesarean-Section. β
Journal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr ) Vol: 63 Issue 6 Pages: 681-687 Pub: 2016 Dec Epub: Authors Garcia Rodenas CL , Lepage M , Ngom-Bru C , Fotiou A , Papagaroufalis K , Berger B , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Role of <i>Lactobacillus reuteri</i> in Human Health and Diseases. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 9 Issue Pages: 757 Pub: 2018 Epub: 2018 Apr 19 Authors Mu Q , Tavella VJ , Luo XM , |
|
|
<i>Lactobacillus reuteri</i> DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. β
Go to Publication β
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2019 Sep 4 Epub: 2019 Sep 4 Authors Liu Y , Tian X , He B , Hoang TK , Taylor CM , Blanchard E , Freeborn J , Park S , Luo M , Couturier J , Tran DQ , Roos S , Wu G , Rhoads JM , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Lactobacillus reuteri Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Mice by Modulating Gut Microbiota. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 385 Pub: 2019 Epub: 2019 Mar 7 Authors He B , Hoang TK , Tian X , Taylor CM , Blanchard E , Luo M , Bhattacharjee MB , Freeborn J , Park S , Couturier J , Lindsey JW , Tran DQ , Rhoads JM , Liu Y , |
|
|
Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling. β
Go to Publication β
Biology direct (Biol Direct ) Vol: 19 Issue 1 Pages: 23 Pub: 2024 Mar 18 Epub: 2024 Mar 18 Authors Zhang L , Gong X , Tan J , Zhang R , Li M , Liu C , Wu C , Li X , |
|
|
Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota. β
Go to Publication β
Microbial pathogenesis (Microb Pathog ) Vol: 188 Issue Pages: 106541 Pub: 2024 Mar Epub: 2024 Jan 13 Authors Wang D , Zeng J , Wujin C , Ullah Q , Su Z , |
|
|
Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice. β
Go to Publication β
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 38 Issue 2 Pages: e23383 Pub: 2024 Jan 31 Epub: Authors He Z , Li W , Yuan W , He Y , Xu J , Yuan C , Zhao C , Zhang N , Fu Y , Hu X , |
|
|
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , |
|
|
Lactobacillus reuteri strain 8008 attenuated the aggravation of depressive-like behavior induced by CUMS in high-fat diet-fed mice through regulating the gut microbiota. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1149185 Pub: 2023 Epub: 2023 Mar 27 Authors Li C , Su Z , Chen Z , Cao J , Liu X , Xu F , |
|
|
Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission. β
Go to Publication β
Microbiome (Microbiome ) Vol: 10 Issue 1 Pages: 211 Pub: 2022 Dec 2 Epub: 2022 Dec 2 Authors Wang G , Wang X , Ma Y , Cai S , Yang L , Fan Y , Zeng X , Qiao S , |
|
|
Lactobacillus reuteri CCFM8631 Alleviates Hypercholesterolaemia Caused by the Paigen Atherogenic Diet by Regulating the Gut Microbiota. β
Go to Publication β
Nutrients (Nutrients ) Vol: 14 Issue 6 Pages: Pub: 2022 Mar 17 Epub: 2022 Mar 17 Authors Wang Q , He Y , Li X , Zhang T , Liang M , Wang G , Zhao J , Zhang H , Chen W , |
|
|
Effects of drinking water supplementation with Lactobacillus reuteri, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens. β
Go to Publication β
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 13 Issue 1 Pages: 34 Pub: 2022 Mar 5 Epub: 2022 Mar 5 Authors Zhang L , Ben Said L , Hervé N , Zirah S , Diarra MS , Fliss I , |
|
|
Effects of drinking water supplementation with Lactobacillus reuteri, and a mixture of reuterin and microcin J25 on the growth performance, caecal microbiota and selected metabolites of broiler chickens. β
Go to Publication β
Journal of animal science and biotechnology (J Anim Sci Biotechnol ) Vol: 13 Issue 1 Pages: 34 Pub: 2022 Mar 5 Epub: 2022 Mar 5 Authors Zhang L , Ben Said L , Hervé N , Zirah S , Diarra MS , Fliss I , |
|
|
Lactobacillus reuteri FYNLJ109L1 Attenuating Metabolic Syndrome in Mice via Gut Microbiota Modulation and Alleviating Inflammation. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 10 Issue 9 Pages: Pub: 2021 Sep 2 Epub: 2021 Sep 2 Authors Yang B , Zheng F , Stanton C , Ross RP , Zhao J , Zhang H , Chen W , |
|
|
[Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice]. β
Go to Publication β
Sheng wu gong cheng xue bao = Chinese journal of biotechnology (Sheng Wu Gong Cheng Xue Bao ) Vol: 36 Issue 9 Pages: 1887-1898 Pub: 2020 Sep 25 Epub: Authors Liu M , Hu R , Guo Y , Sun W , Li J , Fan M , Wang Y , Du H , Tang Z , Chai C , |
|
|
Protective Effect of Probiotics against Pseudomonas aeruginosa Infection of Human Corneal Epithelial Cells. β
Go to Publication β
International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue 3 Pages: Pub: 2024 Feb 1 Epub: 2024 Feb 1 Authors Paterniti I , Scuderi SA , Cambria L , Nostro A , Esposito E , Marino A , |
|
|
Synergistic activity of Limosilactobacillus reuteri KUB-AC5 and water-based plants against Salmonella challenge in a human in vitro gut model. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 4730 Pub: 2024 Feb 27 Epub: 2024 Feb 27 Authors Mok K , Honwichit O , Funnuam T , Charoensiddhi S , Nitisinprasert S , Nielsen DS , Nakphaichit M , |
|
|
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. β
Go to Publication β
Life sciences (Life Sci ) Vol: 314 Issue Pages: 121309 Pub: 2023 Feb 1 Epub: 2022 Dec 20 Authors Lin C , Zheng Y , Lu J , Zhang H , Wang G , Chen W , |
|
|
Exopolysaccharides from camel milk-derived Limosilactobacillus reuteri C66: Structural characterization, bioactive and rheological properties for food applications. β
Go to Publication β
Food chemistry: X (Food Chem X ) Vol: 25 Issue Pages: 102164 Pub: 2025 Jan Epub: 2025 Jan 27 Authors Kober AKMH , Abdin M , Subhash A , Liu SQ , Dertli E , Abu-Jdayil B , Show PL , Ayyash M , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
